Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mindfulness program aims to ease lung cancer breathlessness

NCT ID NCT07281300

Symptom relief Sponsor: The Hong Kong Polytechnic University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 18, 2026 · Updated 2 times

Summary

This study tests a 6-week mindfulness-based program for lung cancer patients struggling with breathlessness, cough, and fatigue. The program combines mindful breathing, relaxation, cough control, acupressure, and light exercise. Researchers will check if it's practical and liked by patients, and also use brain scans to see how it affects the brain.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mindfulness-Oriented Respiratory Distress Symptom Intervention (M-RDSI) - a behavioral program combining mindfulness, breathing techniques, acupressure, and exercise
What this could lead to
If it works, this could offer a new way to manage tough symptoms like breathlessness and fatigue in lung cancer patients, improving daily life.
What could go wrong
This is a small feasibility study with only 64 participants, so results may not apply to everyone. It's too early to know if the program truly helps or just seems promising.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

70 people

The number who actually took part.

Started

Aug 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * HK patients who can understand Cantonese, aged 18 years or older; * A confirmed diagnosis of an intrathoracic malignancy, including small cell lung cancer, non-small cell lung cancer, or mesothelioma; at any stage of cancer treatment or palliative care; * Self-reported impact on daily life from at least two of the three symptoms, where one symptom is breathlessness; * Stability of COPD, if present; * WHO Performance Status of 0-2; * fMRI can be conducted; * Expected lifespan of more than six months. Exclusion Criteria: * Cognitive impairments, severe psychotic symptoms, or other medical conditions that might hinder participation; * Participating in mindfulness or other psychological support interventions or symptom management interventions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Brain activity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cough Dyspnea Fatigue lung cancer mesothelioma non-small cell lung carcinoma small cell lung carcinoma syndromic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Brain activity Breathlessness Coughing Fatigue symptom Lung cancer patients Symptom cluster

Contacts and locations

Locations

  • The Hong Kong Polytechnic University

    Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.